NHS Commercial Framework for New Medicines – consultation phase 1

Overview

NHS England has published a consultation document which sets out proposals for updating the NHS Commercial Framework for New Medicines. The proposals include:

• indication-specific pricing arrangements and the circumstances in which they will be considered 
• a reflection of the Competition and Markets Authority prioritisation statement on combination therapies 
• embedding the provisions and principles supporting patient access schemes into the Commercial framework for new medicines 

We would like to hear from anyone with an interest in the subject of the consultation. We are committed to involving patients and potential future patients in the development of the Commercial Framework for New Medicines, and we are particularly keen to hear from as many patients, carers and patient representatives as possible to inform these proposals.